We had so much fun during our 1st Annual Golf for a Cure last year, while raising over $60,000 for pediatric cancer! So let’s do it again, Charlotte! Team Build. Entertain clients. Practice Your Swing. Increase your sales. Strengthen Your Community Involvement. Give Back to Charlotte.
Join us for our 2nd Annual Golf for a Cure presented by Y-mAbs Therapeutics at Firethorne Country Club on Monday, June 27th, 2022. Thank you to our participating sponsors who are helping make sure this event is a success!
We have several ways to participate and help us raise funds for pediatric cancer research: Business sponsorships, hole sponsors, flag sponsors, and limited foursomes are available. The day includes golf, lunch, drink tickets, contests, charity golf guns, raffle & auction, and an awards reception… and of course knowing you are making a difference in our Charlotte community. Join us and make a difference while networking in your community. Sign up for a corporate sponsorship or purchase a foursome before they are sold out.
There is no better time to get involved than right now. We are building a global pediatric cancer program at Levine Children’s with world-renowned cancer researcher, Dr. Sholler, at the helm… and it has taken off! The Isabella Santos Foundation Rare & Solid Tumor Program has become an international and national destination for healthcare for children with solid tumors, brain cancers, and rare cancers. With your support, we can help increase the survival rates of kids with cancer.
Founded to Fight Neuroblastoma: Y-mAbs Therapeutics is a commercial-stage clinical biopharmaceutical company focused on the development and commercialization of novel antibody-based cancer treatments. Their mission is to become the world leader in developing antibody-based cancer products that address clear unmet needs in pediatric oncology. Learn More.
“My goal is to have these antibodies available worldwide, so that everyone has the same options my daughter and family had.” [Thomas Gad, founder of Y-mAbs & father of Daniella, a high-risk neuroblastoma survivor]